News from neurotrope, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Apr 23, 2015, 08:00 ET

Neurotrope Joins National Organization for Rare Disorders (NORD) Corporate Council

 Neurotrope, Inc. (OTCQB: NTRP) today announced that, based upon its work in orphan drug indications, it has been invited to join the National...

Apr 20, 2015, 07:55 ET

Neurotrope Receives Research Grant From the FRAXA Research Foundation to Fund Pre-Clinical Fragile X Syndrome Behavioral Studies

 Neurotrope, Inc. (OTCQB: NTRP) today announced that eurotrope BioScience, Inc., its wholly-owned operating subsidiary, has received a grant...

Apr 09, 2015, 08:00 ET

Neurotrope Receives FDA Orphan Drug Designation for Bryostatin in the Treatment of Fragile X Syndrome

 Neurotrope, Inc. (OTCQB: NTRP) today announced that Neurotrope BioScience, Inc., its wholly-owned operating subsidiary, (the...

Apr 06, 2015, 08:00 ET

Neurotrope Selects Worldwide Clinical Trials to Commence Services for Phase 2B Trial of Bryostatin for the Treatment of Alzheimer's Disease

Neurotrope, Inc. (OTCQB: NTRP) today announced that Neurotrope Bioscience, Inc., its wholly-owned operating subsidiary, (the "Company") has...

Mar 17, 2015, 07:00 ET

Neurotrope Announces Positive Final Results From its Phase 2a Safety Study for the Treatment of Alzheimer's Disease

Neurotrope, Inc. (OTCQB: NTRP) today announced secondary and exploratory endpoint results from its randomized, double-blind, placebo-controlled,...

Feb 24, 2015, 07:00 ET

Neurotrope Announces Positive Top-Line Results From Its Phase 2a Study of Bryostatin-1 in Alzheimer's Disease

 Neurotrope, Inc. (OTCQB: NTRP) today announced positive top-line results from its randomized, double-blind, placebo-controlled, single dose...

Jan 14, 2015, 08:30 ET

Neurotrope Forms Clinical Advisory Board to Support Alzheimer's Disease Program

 Neurotrope, Inc. (OTCQB: NTRP) today announced the formation of its Alzheimer's Disease Clinical Advisory Board (CAB) with the following...

Jan 07, 2015, 08:30 ET

Neurotrope to Present at the Biotech Showcase 2015 Conference

 Neurotrope, Inc. (OTCQB: NTRP) today announced it is scheduled to present at the Biotech Showcase 2015 Conference being held at the Parc 55...

Nov 20, 2014, 08:30 ET

Neurotrope Announces Last Patient Dosed in Phase 2a Clinical Trial of Bryostatin-1 for Alzheimer's Disease

 Neurotrope, Inc. (OTCQB: NTRP) announced today that the last patient has been dosed in its Phase 2a clinical trial of Bryostatin-1 for the...

Nov 06, 2014, 08:30 ET

Neurotrope Appoints Warren W. Wasiewski, M.D. as Executive Vice President, Development and Chief Medical Officer

Neurotrope, Inc. (OTCQB: NTRP) today announced that Warren W. Wasiewski, M.D., F.A.A.P. has joined Neurotrope BioScience, Inc., the Company's...

Sep 18, 2014, 08:30 ET

Larry D. Altstiel, M.D., Ph.D. Joins Neurotrope Board of Directors

 Neurotrope, Inc. (OTCQB: NTRP) today announced the appointment of Larry D. Altstiel, M.D., Ph.D. to the Company's Board of Directors,...

Aug 20, 2014, 13:30 ET

Neurotrope To Host Conference Call

Neurotrope, Inc. (OTCQB: NTRP) today announced that it will host a conference call to provide an update on Company activities. Access...

Aug 18, 2014, 09:13 ET
Jul 29, 2014, 08:30 ET

Neurotrope Initiates Phase 2a Study of Bryostatin for the Treatment of Alzheimer's Disease - Doses First Patients

 Neurotrope, Inc. (OTCQB: NTRP) announced today that it has initiated a Phase 2a clinical trial to evaluate bryostatin for the treatment of...

Jul 22, 2014, 08:30 ET

Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C

 Neurotrope Bioscience, Inc., a subsidiary of Neurotrope, Inc. (OTCQB: NTRP) has signed a world-wide, exclusive license agreement with the...

Jul 18, 2014, 13:04 ET

Neurotrope Board of Directors Appoints Chairmen Ramat and Freiman as Interim Co-CEOs

 Neurotrope, Inc. (OTCQB: NTRP) today announced that on July 16, 2014,  its Board of Directors appointed Co-Chairmen Charles S. Ramat and...

Jun 19, 2014, 08:30 ET

Neurotrope Appoints Charles S. Ramat and Paul Freiman as Co-Chairmen of the Board

 Neurotrope, Inc. (OTCQB: NTRP) has appointed Messrs. Charles S. Ramat and Paul Freiman as Co-Chairmen of its Board of Directors. Mr. Freiman...

Jun 04, 2014, 08:30 ET

Neurotrope Appoints Neuroscientist Sam Kongsamut as Executive Director, Pharmacology

 Neurotrope, Inc. (OTCQB: NTRP) announced today the appointment of Sam Kongsamut, Ph.D., as Executive Director, Pharmacology, effective...

May 28, 2014, 08:30 ET

Neurotrope Announces Publication of Positive Human Cell Culture and Mouse Model Data of Bryostatin 1

 Neurotrope, Inc. (OTCQB: NTRP) announced today the publication of positive human cell culture and mouse model data of Bryostatin 1 in two peer...

May 20, 2014, 08:30 ET

Neurotrope, Inc. Collaborating with Dr. Paul Wender and Stanford University on Bryostatin Analogues

 Neurotrope, Inc. (OTCQB: NTRP) (the "Company") announced today that it has signed an agreement with Stanford University to study and, along...